Deep Track Capital LP 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:43 am Sale | 2024-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital LP | 131,733 1.070% | -929,777 (-87.59%) | Filing |
| 2024-11-14 09:18 am Sale | 2024-09-30 | 13G | Nektar Therapeutics NKTR | Deep Track Capital LP | 1,061,510 8.650% | -165,156 (-13.46%) | Filing |
| 2024-02-14 08:50 am Purchase | 2023-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital LP | 1,226,667 9.650% | 406,518 (+49.57%) | Filing |
| 2023-04-14 4:34 pm Purchase | 2023-04-04 | 13G | Nektar Therapeutics NKTR | Deep Track Capital LP | 820,149 6.500% | 820,149 (New Position) | Filing |